World's Best Scientists 2026 revealed!
Award Badge
Immunology
Israel
2026

D-Index & Metrics

Immunology

D-Index
87
Citations
33559
World Ranking
1201
National Ranking
9

Medicine

D-Index
87
Citations
33634
World Ranking
13505
National Ranking
33

Shimon Slavin publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Shimon Slavin sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 558 publications — 92nd percentile

92% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Shimon Slavin D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Shimon Slavin sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 87 D-Index — 76th percentile

76% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Research.com Recognitions

  • 2026 - Research.com Immunology in Israel Leader Award
  • 2025 - Research.com Immunology in Israel Leader Award
  • 2023 - Research.com Immunology in Israel Leader Award
  • 2022 - Research.com Immunology in Israel Leader Award

Overview

Shimon Slavin is affiliated with the Hebrew University of Jerusalem in Israel. Their research primarily spans the fields of Medicine and Immunology and Microbiology, with a particular focus on Immunology, Oncology, and Hematology. The scientist's work also covers subfields such as Infectious Diseases and Epidemiology.

The research topics covered by Slavin include:

  • Immune Cell Function and Interaction
  • Hematopoietic Stem Cell Transplantation
  • CAR-T cell therapy research
  • SARS-CoV-2 and COVID-19 Research
  • Immune responses and vaccinations
  • Virology and Viral Diseases
  • T-cell and B-cell Immunology

Frequent co-authors with whom Slavin has collaborated include:

  • Tibor Bakács
  • Volker Sandig
  • Imre Kovesdi
  • Parameswaran Hari
  • Jeanette Carreras

The main venues where Slavin's work has been published are:

  • UNC Libraries
  • Research Square (Research Square)
  • Infectious Disorders - Drug Targets
  • Preprints.org
  • Journal of Cancer Research and Clinical Oncology

Recent papers authored or co-authored by Slavin include:

  • "Immunotherapy with cure potential of multi-drug resistant hematologic malignancies using IL-2 preactivated intentionally mismatched donor lymphocyte", 2023, Journal of Cancer Research and Clinical Oncology
  • "Cell-mediated immunotherapy: A new frontier in preventing disease progression and treating drug-resistant cancer", 2025, Med

Other notable publications associated with frequent co-authors, relevant to the broader scientific context, include:

  • "A Clinically Validated, Broadly Active, Oral Viral SuperinfectionTherapy Could Mitigate Symptoms in Early-stage COVID-19 Patients", 2022, Infectious Disorders - Drug Targets
  • "The clinically validated viral superinfection therapy (SIT) platform technology could cure early cases of COVID-19 disease", 2021, Preprints.org
  • "Reduced-Intensity Allografting as First Transplantation Approach in Relapsed/Refractory Grades One and Two Follicular Lymphoma Provides Improved Outcomes in Long-Term Survivors", 2020, UNC Libraries

Best Publications

  • Nonmyeloablative Stem Cell Transplantation and Cell Therapy as an Alternative to Conventional Bone Marrow Transplantation With Lethal Cytoreduction for the Treatment of Malignant and Nonmalignant Hematologic Diseases

    Shimon Slavin;Arnon Nagler;Ella Naparstek;Yossi Kapelushnik

  • Defining the intensity of conditioning regimens: working definitions.

    Andrea Bacigalupo;Karen Ballen;Doug Rizzo;Sergio Giralt

  • Correction of ADA-SCID by Stem Cell Gene Therapy Combined with Nonmyeloablative Conditioning

    Alessandro Aiuti;Shimon Slavin;Memet Aker;Francesca Ficara

  • Safety and immunological effects of mesenchymal stem cell transplantation in patients with multiple sclerosis and amyotrophic lateral sclerosis.

    Dimitrios Karussis;Clementine Karageorgiou;Adi Vaknin-Dembinsky;Basan Gowda-Kurkalli

  • Gene Therapy for Immunodeficiency Due to Adenosine Deaminase Deficiency

    Alessandro Aiuti;Federica Cattaneo;Stefania Galimberti;Ulrike Benninghoff

  • Comparative outcome of reduced intensity and myeloablative conditioning regimen in HLA identical sibling allogeneic haematopoietic stem cell transplantation for patients older than 50 years of age with acute myeloblastic leukaemia: a retrospective survey from the Acute Leukemia Working Party (ALWP) of the European group for Blood and Marrow Transplantation (EBMT).

    M. Aoudjhane;M. Labopin;N. C. Gorin;A. Shimoni

  • ELIMINATION OF GRAFT-VERSUS-HOST DISEASE BY IN-VITRO DEPLETION OF ALLOREACTIVE LYMPHOCYTES WITH A MONOCLONAL RAT ANTI-HUMAN LYMPHOCYTE ANTIBODY (CAMPATH-1)

    H. Waldmann;G. Hale;G. Cividalli;Z. Weshler

  • Allogeneic cell therapy with donor peripheral blood cells and recombinant human interleukin-2 to treat leukemia relapse after allogeneic bone marrow transplantation.

    Shimon Slavin;Elizabeth Naparstek;Arnon Nagler;Aliza Ackerstein

  • Induction of specific tissue transplantation tolerance using fractionated total lymphoid irradiation in adult mice: long-term survival of allogeneic bone marrow and skin grafts.

    Shimon Slavin;Samuel Strober;Zvi Fuks;Henry S. Kaplan

  • Infusion of suicide-gene-engineered donor lymphocytes after family haploidentical haemopoietic stem-cell transplantation for leukaemia (the TK007 trial): a non-randomised phase I–II study

    Fabio Ciceri;Chiara Bonini;Maria Teresa Lupo Stanghellini;Attilio Bondanza

  • Neuroprotection and immunomodulation with mesenchymal stem cells in chronic experimental autoimmune encephalomyelitis.

    Ibrahim Kassis;Nikolaos Grigoriadis;Basan Gowda-Kurkalli;Rachel Mizrachi-Kol

  • Reduced-Intensity Conditioning Compared With Conventional Allogeneic Stem-Cell Transplantation in Relapsed or Refractory Hodgkin's Lymphoma: An Analysis From the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation

    Anna Sureda;Stephen Robinson;Carmen Canals;Angelo M. Carella

  • Spontaneous murine B-cell leukaemia.

    Shimon Slavin;Shimon Slavin;Samuel Strober

  • Allogeneic cell therapy for relapsed leukemia after bone marrow transplantation with donor peripheral blood lymphocytes.

    S. Slavin;E. Naparstek;A. Nagler;A. Ackerstein

  • Treatment of chronic granulomatous disease with myeloablative conditioning and an unmodified hemopoietic allograft: a survey of the European experience, 1985-2000.

    Reinhard A. Seger;Tayfun Gungor;Bernd H. Belohradsky;Stephane Blanche

  • Multilineage hematopoietic reconstitution without clonal selection in ADA-SCID patients treated with stem cell gene therapy

    Alessandro Aiuti;Barbara Cassani;Grazia Andolfi;Massimiliano Mirolo

  • Mini-allografts: ongoing trials in humans.

    A. M. Carella;R. Champlin;S. Slavin;P. McSweeney

  • Induction of tolerance in autoimmune diseases by hematopoietic stem cell transplantation: getting closer to a cure?

    Richard K. Burt;Shimon Slavin;William H. Burns;Alberto M. Marmont

  • Reduced-intensity transplantation for lymphomas using haploidentical related donors vs HLA-matched unrelated donors.

    Abraham S. Kanate;Alberto Mussetti;Mohamed A. Kharfan-Dabaja;Kwang W. Ahn;Kwang W. Ahn

  • Autologous stem cell transplantation for progressive multiple sclerosis: update of the European Group for Blood and Marrow Transplantation autoimmune diseases working party database.

    R Saccardi;T Kozak;C Bocelli-Tyndall;A Fassas

Frequent Co-Authors

Arnon Nagler
Arnon Nagler Sheba Medical Center
Chaim Brautbar
Chaim Brautbar Hebrew University of Jerusalem
Claudio Bordignon
Claudio Bordignon MolMed (Italy)
Chaya Brodie
Chaya Brodie Henry Ford Health System
Hillard M. Lazarus
Hillard M. Lazarus Case Western Reserve University
Chiara Bonini
Chiara Bonini Vita-Salute San Raffaele University
Jane F. Apperley
Jane F. Apperley Imperial College London
Alessandro Aiuti
Alessandro Aiuti Vita-Salute San Raffaele University
Fabio Ciceri
Fabio Ciceri Vita-Salute San Raffaele University
Israel Vlodavsky
Israel Vlodavsky Technion – Israel Institute of Technology

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, pursuing related healthcare degrees can open diverse career opportunities. Many students opt for nursing paths, especially specialized roles like psychiatric mental health nurse practitioners (PMHNPs). Exploring the easiest nurse practitioner program options online can help you find flexible and accessible pathways tailored to your needs.

When selecting programs, clinical placement quality is crucial for gaining hands-on experience. The best online psychiatric mental health nurse practitioner programs stand out by combining strong academic support with excellent clinical opportunities.

Cost is another important factor to consider. Fortunately, some of the cheapest online pmhnp programs offer quality education without the financial strain, making advanced degrees more attainable for many students.

Career-wise, nurse practitioners with Doctor of Nursing Practice (DNP) degrees enjoy rewarding salaries. You can see detailed data on how much do dnp nurses make across different states to better understand earning potential in various regions.

Best Scientists Citing Shimon Slavin

Trending Scientists

Recently Published Articles